Literature DB >> 4949510

Antibodies produced by rabbits immunized with visna virus.

S C Karl, H Thormar.   

Abstract

Immunization of New Zealand White rabbits with purified visna virus elicited antibody activity demonstrated by passive hemagglutination (PHA), complement fixation (CF), and indirect immunofluorescent tests. The antibody activities of hyperimmune sera and Sephadex G-200 fractions of the sera were studied. It was found that the PHA test was 10 to 100 times more sensitive than the CF test in detecting visna antibodies in rabbits. It was also found that the immunoglobulin M fractions from Sephadex G-200 filtration displayed greater PHA activity than did the immunoglobulin G fractions. Although neutralizing antibody was demonstrated in the serum of the natural host (sheep), our attempts to demonstrate neutralizing antibody in the sera from hyperimmunized rabbits (non-natural host) so far have failed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4949510      PMCID: PMC416379          DOI: 10.1128/iai.4.6.715-719.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells.

Authors:  A B STAVITSKY
Journal:  J Immunol       Date:  1954-05       Impact factor: 5.422

3.  Complement-fixing antibodies in sera of sheep affected with visna and maedi.

Authors:  M Gudnadóttir; K Kristinsdóttir
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

4.  Hemagglutination studies of the viral antigen in a murine leukemia (Rauscher).

Authors:  L R Sibal; M A Fink; J L Vice; B L Brandt; T E O'Connor
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

5.  A comparison of visna and maedi viruses. II. Serological relationship.

Authors:  H Thormar; H Helgadóttir
Journal:  Res Vet Sci       Date:  1965-10       Impact factor: 2.534

6.  Visna and maedi virus antigen in infected cell cultures studied by the fluorescent antibody technique.

Authors:  H Thormar
Journal:  Acta Pathol Microbiol Scand       Date:  1969

7.  Application of passive hemagglutination methods for detection of antibody to viral antigen in hamsters bearing adenovirus type 12 tumors.

Authors:  S S Lefkowitz
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

8.  Ribonucleic acid-dependent deoxyribonucleic acid polymerase in visna virus.

Authors:  F H Lin; H Thormar
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

9.  Characterization of ribonucleic acid from visna virus.

Authors:  F H Lin; H Thormar
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

10.  Immunofluorescence and cytochemical studies of visna virus in cell culture.

Authors:  D H Harter; K C Hsu; H M Rose
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

  10 in total
  5 in total

1.  Comparative studies of Visna and Maedi viruses as antigens.

Authors:  P D Mehta; H Thormar
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  Infectious virus-antibody complexes of sindbis virus.

Authors:  J Symington; A K McCann; M J Schlesinger
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Neutralizing activity in isolated serum antibody fractions from visna-infected sheep.

Authors:  P D Mehta; H Thormar
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

4.  Long-term Visna virus infection of sheep choroid plexus cells: initiation and preliminary characterization of the carrier cultures.

Authors:  R S Trowbridge
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

5.  Antigenic analysis of isolated polypeptides from Visna virus.

Authors:  P D Mehta; F H Lin; H Thormar
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.